| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Sep 30 | P | 30,000 | $37.38 | $1.1M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 12 | MPLAN | 12,500 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 13 | SPLAN | 7,308 | $55.23 | $404K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 12 | MPLAN | 12,500 | — | — |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 9 | MPLAN | 20,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 9 | APLAN | 20,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 9 | MPLAN | 65,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 9 | MPLAN | 105,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 9 | MPLAN | 25,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Mar 9 | MPLAN | 75,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 10 | SPLAN | 11,269 | $60.11 | $677K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | MPLAN | 20,000 | — | — |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 65,000 | $62.06 | $4.0M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | MPLAN | 65,000 | $9.44 | $614K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 61,652 | $60.08 | $3.7M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 43,348 | $59.26 | $2.6M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | MPLAN | 105,000 | $4.75 | $499K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 2,449 | $61.26 | $150K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 10,072 | $60.47 | $609K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 12,479 | $59.50 | $743K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | MPLAN | 25,000 | $3.10 | $78K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 21,515 | $60.49 | $1.3M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 31,694 | $59.88 | $1.9M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | SPLAN | 21,791 | $58.81 | $1.3M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Mar 9 | MPLAN | 75,000 | $8.40 | $630K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Jan 9 | A | 65,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Jan 9 | A | 350,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEODERIV | Jan 2 | MPLAN | 40,000 | $0.00 | —? |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Jan 2 | SPLAN | 2,062 | $44.93 | $93K |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Jan 2 | SPLAN | 37,938 | $44.40 | $1.7M |
| Xenon Pharmaceuticals Inc. | XENE | Ian MortimerCEO | Jan 2 | MPLAN | 40,000 | $7.49 | $300K |